Your browser doesn't support javascript.
loading
Oral Anticancer Heterobimetallic PtIV -AuI Complexes Show High In Vivo Activity and Low Toxicity.
Babu, Tomer; Ghareeb, Hiba; Basu, Uttara; Schueffl, Hemma; Theiner, Sarah; Heffeter, Petra; Koellensperger, Gunda; Metanis, Norman; Gandin, Valentina; Ott, Ingo; Schmidt, Claudia; Gibson, Dan.
Afiliação
  • Babu T; Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, 91120, Israel.
  • Ghareeb H; Institute of Chemistry, The Center for Nanoscience and Nanotechnology, Casali Center for Applied Chemistry, The Hebrew University of Jerusalem, Jerusalem, 9190401, Israel.
  • Basu U; Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, 38106, Braunschweig, Germany.
  • Schueffl H; Center for Cancer Research and Comprehensive Cancer Center, Austria.
  • Theiner S; Institute of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090, Vienna, Austria.
  • Heffeter P; Center for Cancer Research and Comprehensive Cancer Center, Austria.
  • Koellensperger G; Center for Cancer Research and Comprehensive Cancer Center, Austria.
  • Metanis N; Institute of Chemistry, The Center for Nanoscience and Nanotechnology, Casali Center for Applied Chemistry, The Hebrew University of Jerusalem, Jerusalem, 9190401, Israel.
  • Gandin V; Dipartimento di Scienze del Farmaco, Universita di Padova, 35131, Padova, Italy.
  • Ott I; Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, 38106, Braunschweig, Germany.
  • Schmidt C; Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, 91120, Israel.
  • Gibson D; Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, 91120, Israel.
Angew Chem Int Ed Engl ; 62(10): e202217233, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36628505

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Antineoplásicos Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Antineoplásicos Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel